Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Langer

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Journal of the National Cancer Institute|January 20, 1993
Radiation-induced chest-wall chondrosarcoma following surgical resection and radiotherapy for non-small-cell lung cancerE R Sauter, S M Keller, W J Curran, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiformeC J Langer, J Ruffer, H Rhodes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patientsN Siegelmann-Danieli, A Hanlon, J A Ridge, et al.
Seminars in Oncology|August 1, 1997
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001C J Langer, B Movsas, R Hudes, et al.
Cancer Investigation|January 1, 1995
Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinomaC J Langer, R Catalano, L M Weiner, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its networkC J Langer, M Millenson, E Rosvold, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2000
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lungR J Schilder, M Goldberg, M M Millenson, et al.
Gynecologic Oncology|December 1, 1991
Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinomaC J Langer, S Nash, R Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynxD A Fein, W R Lee, A L Hanlon, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Journal of the National Cancer Institute|January 20, 1993
Radiation-induced chest-wall chondrosarcoma following surgical resection and radiotherapy for non-small-cell lung cancerE R Sauter, S M Keller, W J Curran, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiformeC J Langer, J Ruffer, H Rhodes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patientsN Siegelmann-Danieli, A Hanlon, J A Ridge, et al.
Seminars in Oncology|August 1, 1997
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001C J Langer, B Movsas, R Hudes, et al.
Cancer Investigation|January 1, 1995
Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinomaC J Langer, R Catalano, L M Weiner, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its networkC J Langer, M Millenson, E Rosvold, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2000
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lungR J Schilder, M Goldberg, M M Millenson, et al.
Gynecologic Oncology|December 1, 1991
Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinomaC J Langer, S Nash, R Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynxD A Fein, W R Lee, A L Hanlon, et al.
Pageof 5